Quality Matters

JUNE 12, 2023

Accounting for approximately 90% of prescriptions filled in the United States , generic medicines are essential to increasing patient access to important drug therapies. health care system—including patients—around $366 billion in 2021 alone according to the Association for Accessible Medicines.

Generic Medicine 52

Generic Medicine Dosage Prescription Filling Diabetes 52

National Association of Boards of Pharmacy

JUNE 6, 2022

This is the gap that new mental health start-ups offering therapy and prescriptions for conditions such as anxiety, depression, insomnia, substance use disorder, and attention deficit hyperactivity disorder (ADHD) have aimed to fill.

Online Pharmacies 52

Online Pharmacies Controlled Substances Prescription Filling 52

Quality Matters

APRIL 26, 2023

Known as the USP Medicine Supply Map and launched in 2021, this capability leverages more than 250 million data points – some proprietary, but mostly public – spanning 92% of generic medicines approved in the U.S. in a platform that assesses the vulnerability of specific medicines to supply chain disruptions.

Prescription Filling 52

Prescription Filling Generic Medicine Packaging Labelling 52

Quality Matters

OCTOBER 13, 2021

can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should. josh.levin@usp.org Wed, 10/13/2021 - 13:07 Supply Chain In fact, quality standards are a big reason why we in the U.S.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Ramblings of a pharmacist

FEBRUARY 16, 2022

The 1957 Lilly Digest reveals that that’s below average - the typical survey-respondent pharmacy did 13502 prescriptions/year. Grandpa’s 31,766th prescription. Anyway – on to the current issue of the Digest (which is the 2021 Digest that summarizes data from 2020 operations). prescription transaction.

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

Putting Patients First Blog

JULY 2, 2024

Prior authorization and association with delayed or discontinued prescription fills. Health Affairs, 38(11) , [link] v Durham, D., Casalino, L., and Richman, B. Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. vi Oehrlein, E.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Putting Patients First Blog

JANUARY 27, 2025

12 Mark Kyle and Natalie Keating, “Prior Authorization and Association with Delayed or Discontinued Prescription Fills,” Journal of Clinical Oncology 42, no. September 2021. link] Health-Care-Costs-2021-Recommendations.pdf. link] Health-Care-Costs-2021-Recommendations.pdf. 18 National Health Council.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Putting Patients First Blog

SEPTEMBER 3, 2024

Prior authorization and association with delayed or discontinued prescription fills. Retrieved from [link] www.ama-assn.org/system/files/prior-authorization-survey.pdf 3 Kyle, M. and Keating, N. Journal of Clinical Oncology, 42(8). link] 4 Chino, F., and Thom, B. The patient experience of prior authorization for cancer care.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

MAY 29, 2024

Prior authorization and association with delayed or discontinued prescription fills. Retrieved from https ://www.ama-assn.org/system/files/prior-authorization-survey.pdf 8 Kyle, M. and Keating, N. Journal of Clinical Oncology, 42(8). link] 9 Chino, F., and Thom, B. The patient experience of prior authorization for cancer care.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Prescription Filling Hospitals 52

Safe Biologics

MARCH 10, 2025

Small molecule drugs make up over 90% of prescriptions filled in the U.S. Yet, since the IRAs implementation in 2021, investment in small molecule drug development has dropped by 70% as manufacturers shift resources toward biologics, which have more favorable financial incentives under the law.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130